title: The D3 dopamine receptor: From structural interactions to function.
abstract: Novel structural and functional aspects of the dopamine (DA) D3 receptors (D3R) have been recently described. D3R expressed in dopaminergic neurons have been classically considered to play the role of autoreceptors inhibiting, as the D2R, DA release. However, evidence for D3R-mediated neurotrophic and neuroprotective effects on DA neurons suggests their involvement in preventing pathological alterations leading to neurodegeneration. On the other hand, given its localization and functional role at postsynaptic striatal levels, the D3R may also be involved in the pathogenesis of movement disorders and psychiatric diseases. Functional interactions of D3R with other receptor systems are crucial for the modulation of several physiological events. On this line, the discovery that the D3R can form heteromers with other receptors has opened the possibility of uncover novel molecular mechanisms of brain functions and dysfunctions. This paper summarizes the functional and physical interactions of D3R with other receptors both at pre-synaptic sites, where it is co-expressed with the D2R and nicotinic receptors, and at post-synaptic sites where it interacts with the DA D1 receptors (D1R). The biochemical and functional properties of the D1R-D3R heteromer will be especially discussed. Both D1R and D3R have been in fact implicated in several disorders, including schizophrenia and motor dysfunctions. Therefore, the D1R-D3R heteromer may represent a potential drug target for the treatment of these diseases.
authors.affiliation: Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy. Electronic address: chiara.fiorentini@unibs.it.
authors.forename: Chiara
authors.initials: C
authors.lastname: Fiorentini
authors.affiliation: Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Savoia
authors.affiliation: Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Bono
authors.affiliation: Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
authors.forename: Paola
authors.initials: P
authors.lastname: Tallarico
authors.affiliation: Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
authors.forename: Cristina
authors.initials: C
authors.lastname: Missale
mesh_terms: D000818:Animals; D019281:Dimerization; D006801:Humans; D009069:Movement Disorders / Q000378:metabolism; D017447:Receptors, Dopamine D1 / Q000378:metabolism; D050637:Receptors, Dopamine D3 / Q000378:metabolism*; D013569:Synapses / Q000378:metabolism*
chemical_list: D017447:Receptors, Dopamine D1; D050637:Receptors, Dopamine D3
keywords: Heterodimerization; L-DOPA-induced dyskinesia; Neurodegeneration